To explore a method of predicting acute graft versus host disease (aGVHD) after unrelated cord blood transplantation (UCBT),the HLA-A,-B,-DRB1 molecular three-dimensional structures in 25 patients with blood disorder who underwent UCBT and their donors were modeled by using molecular modeling techonique.

Preliminary experiences on the treatment graft versus host disease after liver transplantation;

Objective To determine the expression of integrin-linked kinase(ILK) in renal tissue of mice with chronic graft versus host disease(cGVHD) lupus nephritis and its relationship with the epithelial-mesenchymal transition.

Objective: To specifically inhibit the graft versus host disease(GVHD) and keep graft versus leukemia(GVL) effect of bone graft through selective deletion of alloreactive lymphocytes from haematopoietic stem cell grafts.

Inhibition effect of rapamycin on acute graft-versus-host disease after allogeneic bone marrow transplantation in a murine model;

Role of paternal veto cells in preventing graft-versus-host disease after HLA-haploidentical stem cell transplantation in mice;

Experimental study on the prevention of mouse graft-versus-host disease by delayed sequential transplantaton;

This study was aimed to explore the relationship between changes of IL-4,IL-6 levels in blood plasma of patients receiving allo-HSCT and aGVHD through dynamical detection.

AIM:To explore a new approach of preventing and treating of aGVHD by investigating the incidence and severity of aGVHD after allogeneic bone marrow transplantation (Allo-BMT) of the Fludarabine preserved cells of donor Rats.

The objective of this study was to explore the occurrence and clinical features of acute graft versus host disease(aGVHD)in non-myeloablative stem cell transplantation(NAST).

This study was aimed to explore the effect of ex vivo chemical modification of graft cells with methoxy polyethylene glycol (mPEG) on graft versus host disease (GVHD) after haploidentical stem cell transplantation in neonatal mice and its influence on activity of the stem cells.

Methods Seven patients with acute/chronic leukemia received HLA completely matched URD-PBSCT following conditioning regimens with cyclophosphamide(Cy)/TBI in 4 cases or busulfan(Bu)/Cy in 3 cases and prophylactic preventing graft-versus-host disease(GVHD) with cyclosporine A(CsA)/methotrexate(MTX)/Mycophenolate mofetil(MMF)/ATG(Thymoglobuline) in 7 cases from Januar.